Kailera Therapeutics, Inc.

KLRA chart

Kailera Therapeutics, Inc. news

• Kailera Therapeutics (NASDAQ:KLRA) Stock Jumps 7.1% - Here's What Happened

  MarketBeat · Nov 10, 1:43 PM EST

• Kailera Therapeutics unveils Phase 3 trial desi...

  Pluang · Nov 10, 7:15 AM EST

• Kailera Therapeutics to Present at ObesityWeek 2026

  Yahoo Finance · Nov 10, 7:00 AM EST

• Researchers will lay out three late-stage obesity drug trial plans and real-world care needs.

  Stock Titan · Nov 10, 7:00 AM EST

• CCORF Initiates Kailera Therapeutics(KLRA.US) With Buy Rating, Announces Target Price $44

  Moomoo · Nov 9, 7:19 PM EST

• Canaccord Genuity initiates coverage of Kailera Therapeutics at Buy, sets price target at $44

  TradingView · Nov 9, 1:00 PM EST

• Kailera Therapeutics (Nasdaq:KLRA) - Stock Analysis

  Simply Wall St · Nov 7, 3:00 AM EST

• What Does Kailera Therapeutics'(NASDAQ:KLRA) Multi-Candidate Obesity Pipeline Look Like Heading Into 2027?

  Kalkine · Nov 5, 3:54 AM EST

• Kailera Therapeutics Q3 Results: Loss narrows to $0.74 per share

  scanx.trade · Nov 4, 6:31 PM EST

• Kailera Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary

  TradingView · Nov 4, 5:40 PM EST

• Kailera Therapeutics Q3 2026 Earnings Results and Report

  MarketBeat · Nov 4, 5:34 PM EST

• Kailera Reports Third Quarter 2026 Financial Results and Provides Business Updates

  Yahoo Finance · Nov 4, 4:05 PM EST

Kailera Therapeutics, Inc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 10-Q10-Q2026-11-04
• 8-K8-K2026-11-04
• 10-Q10-Q2026-08-12
• 8-K8-K2026-08-12
• 10-Q10-Q2026-05-26
• 8-K8-K2026-05-26
• 8-K8-K2026-04-20
• S-1S-12026-03-27

About Kailera Therapeutics, Inc.

Ticker

KLRA (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Waltham, MA

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

2096997

Frequently asked questions